Andrea Seitzinger

Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia

Dirk Dressler, Sebastian Paus, Andrea Seitzinger et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 53 citations · Full text

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands

Johan L. van der Plas, Vincent P. Kuiper, Wilhelmina Bagchus et al. · The Lancet Infectious Diseases · 2023 · 19 citations · Full text

Malaria, Pharmacology, Causal Chemoprophylactic Activity +5

Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis

Mark S. Freedman, Dominic Jack, Zuzana Murgašová et al. · Multiple Sclerosis and Related Disorders · 2021 · 14 citations · Full text

The Dystonia Discomfort Scale (<scp>DDS</scp>): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia

Dirk Dressler, Andreas Kupsch, Andrea Seitzinger et al. · European Journal of Neurology · 2014 · 11 citations · Full text

Efficacy and safety results after &gt;3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study

Xavier Montalbán, Karolina Piasecka‐Stryczynska, Jens Kühle et al. · Multiple Sclerosis Journal · 2024 · 10 citations · Full text